about
Long-term Results of a Cardiology Postgraduate Program.Comment on "MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction"Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.MicroRNAs: a new paradigm in the treatment and diagnosis of heart failure?The emerging role of miR-208a in the heart.MicroRNAs: new players in heart failure.Blood Gene Signatures of Chagas Cardiomyopathy With or Without Ventricular Dysfunction.The new mutation L321F in Candida albicans ERG11 gene may be associated with fluconazole resistance.Whole genome Cardiac DNA methylation fingerprint and gene expression analysis provide new insights in the pathogenesis of Chronic Chagas disease Cardiomyopathy.Is the S405F mutation in Candida albicans ERG11 gene sufficient to confer resistance to fluconazole?Exercise capacity in early and late adult heart transplant recipients.SSCP is not suitable as screening technique to detect mutations in ERG11 gene from Candida species.Integration of miRNA and gene expression profiles suggest a role for miRNAs in the pathobiological processes of acute Trypanosoma cruzi infection.Circulating mir-208a fails as a biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.Carvedilol for Prevention of Chemotherapy Related Cardiotoxicity.Impact of Delayed Whole Blood Processing Time on Plasma Levels of miR-1 and miR-423-5p up to 24 Hours.Determinants of peak VO2 in heart transplant recipients
P50
Q33848748-5FD845C2-92ED-4E22-8522-6F6A67C167CCQ36409311-E7A9C33F-CACA-4B9B-BACB-55D1F38CAC7DQ37701713-8954FA25-528C-4971-954A-7839FA82D770Q38021918-35F656CF-2B4D-4AD6-8947-5FA08ADEA0F0Q38057365-6C36914E-0368-4C92-B251-DB9CFD53352CQ38067639-8FE3728B-8E60-45C8-A245-CF8076F90EAEQ39003348-0C0D7803-A1AF-4089-A013-F13B33C8B5E8Q39321924-C9CC2B1C-227C-4E38-B2E3-B522C053A609Q40187464-B17D2179-ACAB-4450-BCF8-EE5283265174Q44589732-B425280F-3A8D-41E5-A59C-E91FF74FF0C2Q46623282-7D03ECC6-AC9D-4B93-9EC2-03D032A0929CQ46752518-1C29D4A0-AD45-4991-892D-E1FB8D6DAA00Q47158357-1C66558D-6076-404E-B8F2-A234F5F2E196Q48178650-7ED066CE-615E-456C-9059-0271BEE20F04Q51740172-98101BF3-5E5B-44E6-959C-2E1AC3F8D507Q52643117-BD83FB8A-DD83-4882-A9C3-615FB8FB9A88Q58854101-97EE3973-316F-4781-9053-16B2A346A39D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vagner Carvalho Rigaud
@ast
Vagner Carvalho Rigaud
@en
Vagner Carvalho Rigaud
@es
Vagner Carvalho Rigaud
@nl
type
label
Vagner Carvalho Rigaud
@ast
Vagner Carvalho Rigaud
@en
Vagner Carvalho Rigaud
@es
Vagner Carvalho Rigaud
@nl
altLabel
Oliveira-Carvalho V
@en
prefLabel
Vagner Carvalho Rigaud
@ast
Vagner Carvalho Rigaud
@en
Vagner Carvalho Rigaud
@es
Vagner Carvalho Rigaud
@nl
P106
P1153
55315619500
P31
P496
0000-0002-1194-9380